By Conor Hale | FierceBiotech | October 30, 2019
Sherlock Biosciences, maker of CRISPR-based field tests, is partnering up with Mologic to develop a suite of rapid and “instrument-free” molecular diagnostics that work without the need for electricity or temperature controls.
The goal is to deliver sophisticated yet simple-to-use medical tests to previously untapped or underserved areas—including in the home, as well as in low-resource settings—and the two companies are enlisting the help of the Bill & Melinda Gates Foundation to do it.
